Search
for
Sort by
Research 30 of 1000+
- Alopecia: A review of laser and light therapies
- Lasers in Hair Growth and Hair Transplantation
- Illuminating current pitfalls in optimal photobiomodulation device development and assessment for treating hair loss
- What to Look for in Red Light Therapy: A Product Guide Backed by Science
- US clinics marketing unproven and unlicensed adipose-derived autologous stem cell interventions
- Laser for Hair Removal
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Photobiomodulation for the management of hair loss
- Supportive Oncodermatology: Addressing dermatologic adverse events associated with oncologic therapies
- Editorial Note on Next-Generation Therapies and Advance Acne Treatment
- Androgenetic alopecia (male pattern hair loss) in the United States: What treatments should primary care providers recommend?
- Bidirectional Barbed Sutures for Wound Closure: Evolution and Applications
- Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- A Simple Decision Tree Suited for Identification of Early Oral Drug Candidates With Likely Pharmacokinetic Nonlinearity by Intestinal CYP3A Saturation
- Innovations in skin microphysiological systems for nonclinical testing and FDA modernization
- Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- A Systematic Review and Meta-analysis of Randomized Controlled Trials of United States Food and Drug Administration-Approved, Home-use, Low-Level Light/Laser Therapy Devices for Pattern Hair Loss: Device Design and Technology.
- Low‐level laser (light) therapy (LLLT) for treatment of hair loss
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- From Eye Care to Hair Growth: Bimatoprost
- A population pharmacokinetic model for individualized regimens of finasteride according to CYP3A5 genotype and liver function
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- Endocrine disorders and hormonal therapy for adolescent acne
- Efficacy and Safety of Spironolactone in Acne Management
- Clinical Trials and Hair Loss